Invented by Prof Walter Bodmer from University of Oxford
- References (2)
- Inventor Info
|Antigen/Gene or Protein Targets||Human complement component 3|
C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates.
Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes.
|Immunogen||Human complement component 3|
|Positive Control||Human primary fibroblasts|
The antibody will bind to C3b and C3c, but not to C3a or C3d.
WM1 antibody inhibits a standard C3 hemolytic assay. The antibody was unable to immunoprecipitate rabbit or mouse C3.
|Research Area||Cell Type or Organelle Marker, Immunology, Neurobiology, Protein Degradation|
There are 2 reference entries for this reagent.View All References
Add an inventor